Early Access — free while we kick the tires
EdgarHawk

IONS IONIS PHARMACEUTICALS INC Insider Trading

Latest: Director Sold $5.8M of Shares · May 2026
1 filing analyzed · Latest 2026-05-06
Insider buys
0
Insider sells
1
Unique insiders
1
Direction
Net selling
May 2026
2026-05-06
low
Joseph Loscalzo Sell
77,289 shares
$5,801,226
@ $75.06
Significance 3/10

Director Joseph Loscalzo exercised options and sold all acquired shares on same day; proceeds exceed $5.8M despite unprofitable fundamentals.

Director Joseph Loscalzo executed a mechanical exercise-and-sell sequence on a single day: acquiring 77,289 shares across six option exercises at prices ranging from $38 to $64, then immediately selling all 77,289 shares at prices near $75, netting approximately $2M in proceeds. This is classic tax-efficient equity compensation vesting, not a bet on the company's direction. Loscalzo's sole prior Form 4 activity was a sale in October 2025, whose outcome is not yet measurable, so no timing pattern can be established from his previous trades at this stock. Ionis itself remains unprofitable on an annual basis despite strong revenue growth, and the stock is trading noticeably below its 52-week high—context that makes the exercise-and-sell pattern routine compensation management rather than a statement about conviction in the business. The net zero share change confirms no cumulative accumulation or reduction in his exposure occurred.

More Chemicals and Allied Products companies

Get alerts for IONS

Add IONS to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access